Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Radiation oncology Stories

2014-04-17 16:26:59

Lumiphore Inc., a pharmaceutical leader in bifunctional chelator design, is developing in vivo radio-diagnostic imaging and site-directed radio-therapeutics, using its proprietary bifunctional radionuclide metal-chelation technology; it has received a National Science Foundation Small Business Innovation Research (SBIR) Phase II Grant entitled "Novel macrocyclic chelating groups for use in targeted radioisotope diagnostic and companion diagnostic/therapeutic applications." BERKELEY,...

2014-04-15 14:48:37

Penn Medicine first to investigate shared decision making in radiation oncology Playing an active role in their radiation treatment decisions leaves cancer patients feeling more satisfied with their care, and may even relieve psychological distress around the experience, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the journal Cancer. In a study of 305 patients undergoing radiation treatment, Neha Vapiwala, MD, an associate professor in...

2014-04-15 12:30:12

Two-part webinar to highlight benefits of molecular imaging in drug development MATTAWAN, Mich., April 15, 2014 /PRNewswire/ -- MPI Research and Translational Imaging Center partners, inviCRO, and 3D Imaging, announce a complementary two-part webinar series that will examine the game-changing benefits of translational research approaches utilizing molecular imaging. Part I of the series, Bridging the Gap with Translational Imaging: Drug Development from Mouse to Man, kicks off on...

2014-04-15 08:28:20

DUBLIN, Apr. 15, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/f9jczp/global_medical ) has announced the addition of the "Global Medical Imaging Reagents Market Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The analysts forecast the Global Medical Imaging Reagents market to grow at a CAGR of 7.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the...

2014-04-11 08:24:43

More than 1,500 oncology professionals hear of pioneering radiosurgery treatments and knowledge-based planning techniques at two Varian-hosted symposia VIENNA, April 11, 2014 /PRNewswire/ -- Cancer experts have reported advances in radiosurgery treatments for the prostate, liver and spine, as well as significant developments in radiation oncology treatment planning using equipment and software from Varian Medical Systems (NYSE: VAR). Speakers at two Varian-hosted symposia at the...

2014-04-11 08:24:27

LA JOLLA, Calif., April 11, 2014 /PRNewswire-iReach/ -- On March 4, 2014, ICB International, Inc., ("ICBI"), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in Parkinson's-like mice at the Keystone Symposium for Parkinson disease (PD) in Keystone,Colorado. Speaking at the symposium, Dr. Anna Cartier, Associate Director of ICBI, presented scientific data and showed images for the first successful live visualization of a-Syn in the brains of mice with and...

2014-04-10 16:24:36

PALO ALTO, Calif., April 10, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today is reporting that it has settled patent litigation with the University of Pittsburgh. Varian will pay a lump sum of approximately $35 million to fully settle this matter. The settlement will be largely recorded in the financial results for the company's second and third quarters of fiscal year 2014. The University of Pittsburgh initiated a patent infringement lawsuit against Varian in 2007...

2014-04-09 16:25:48

MONTREAL, April 9, 2014 /PRNewswire/ - Jubilant DraxImage Inc., a Jubilant Life Sciences Company, is pleased to announce the appointment of Mr. Michael Rossi as Vice President, Sales and Business Operations, Jubilant DraxImage Inc., with effect from the 21(st) April 2014. Mr. Rossi has worked for GE Healthcare, Life Sciences since 2002, and currently holds the position of General Manager, Global SPECT Business. During his tenure with GE, he has led several commercial organizations...

2014-04-07 16:35:29

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. Dr Trine Grantzau (MD) told the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna: "We found that for each Gray delivered to the lung as part of radiotherapy for a breast tumour, the relative risk of...

2014-04-07 15:55:09

For the first time, researchers have been able to demonstrate that the use of helium ions in radiation therapy could provide accurate treatment to tumors while helping to spare healthy organs. A treatment planning study to be presented at the ESTRO 33 congress today [Sunday] has been able to show that helium may have effects that are superior to radiotherapy using protons, themselves a considerable advance on conventional photon beam radiotherapy. Mr Hermann Fuchs, a PhD student at the...